Wegovy comparison and guidance in the UK
This guide explains who may qualify for Wegovy in the UK, how private eligibility usually differs from NHS access, what health information a prescriber will want to check, and when extra caution or specialist review may be needed.
In UK private practice, Wegovy eligibility is commonly aligned with the licensed criteria used in the product information. That usually means adults with a body mass index of 30 or above, or 27 or above if there is at least 1 weight-related comorbidity.
Height and weight need to be current and measured properly, especially if you are close to a threshold.
Expect questions about digestion, gallbladder history, pancreatitis, diabetes, and other medical issues.
Your clinician will want to know what else you take, especially diabetes treatment and other regular medicines.
Pregnancy planning, contraception, and breastfeeding status are important screening questions.
The strongest way to understand Wegovy eligibility is to separate the question into four parts: adult status, BMI, related health conditions, and clinical suitability.
Wegovy for weight management is used in adults, not children.
Your BMI is the main starting point for both private and NHS-style assessment.
This matters especially if your BMI is 27 to 29.9 rather than 30 and above.
Pregnancy, allergies, and other medical factors can change the answer even if BMI is in range.
Private prescribing and NHS access use different frameworks. It is important not to mix them together.
| Route | Main threshold | How conditions matter | What this means in practice |
|---|---|---|---|
|
Private prescribing Private | BMI 30 or above, or BMI 27 or above with at least 1 weight-related comorbidity. | A related condition can bring someone in at BMI 27 to 29.9 rather than waiting until BMI 30. | This is the route many online clinics and pharmacies commonly assess against first. |
|
NHS semaglutide under NICE NHS | At least 1 weight-related comorbidity plus BMI 35 or above, or exceptionally BMI 30 to 34.9 if referred to tier 3 services. | A comorbidity is required, and the person must also fit the specialist-service pathway. | NHS access is narrower and more structured than the usual private assessment route. |
|
Lower BMI thresholds Care point | Thresholds are usually reduced by 2.5 for some ethnic backgrounds. | This can matter for both private discussion and NHS-style interpretation. | It is especially relevant if you are close to the usual cut-off. |
A weight-related comorbidity is part of the common licensed route when BMI is at least 27 but below 30. The exact wording and evidence a provider wants can vary, but these are the kinds of issues that usually matter clinically.
NHS semaglutide access is not just about whether the medicine is licensed. It also depends on NICE rules, local service pathways, specialist weight management teams, and capacity.
Eligibility is not only about BMI. A prescriber also needs to decide whether Wegovy is appropriate for you as an individual.
| Situation | Why it matters | Usual response |
|---|---|---|
| Pregnancy or planned pregnancy | Wegovy should not be used during pregnancy, and treatment should be stopped before a planned pregnancy. | Do not start or continue without clinical advice. |
| Breastfeeding | Use is not recommended while breastfeeding. | A clinician will usually advise against it. |
| History of pancreatitis or gallbladder problems | Digestive and gallbladder issues can be important in semaglutide assessment. | Needs careful review before prescribing. |
| Severe digestive motility problems | Wegovy slows stomach emptying and may not suit everyone with major GI issues. | Extra caution or alternative planning may be needed. |
| Diabetes treatment | Other diabetes medicines can change risk, especially around low blood sugar. | Medication review is important. |
| Hypersensitivity to semaglutide or ingredients | This is a true contraindication. | Do not use. |
The next decision is not only whether you qualify. It is also which provider fits your needs best on price, support, follow-up, and clarity.
Use the live comparison to review current provider information, then confirm final terms directly on the provider site before proceeding.
Loading price comparison...
These are the eligibility questions visitors most often want answered quickly.
These pages help if you want to check pricing, side effects, or practical use before deciding on a provider.
Review price context, fee structure, and what to compare beyond the headline number.
SupportCheck the most common digestive side effects and what usually helps.
Practical useRead the dosing, injection, storage, and missed-dose guide in one place.
If you look like a realistic candidate, the next step is comparing providers carefully on current fees, follow-up structure, and overall fit rather than price alone.